DOCSLIB.ORG

Molecular Basis of Tank-Binding Kinase 1 Activation by Transautophosphorylation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Molecular Basis of Tank-Binding Kinase 1 Activation by Transautophosphorylation Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation Xiaolei Maa,1, Elizabeth Helgasonb,1, Qui T. Phungc, Clifford L. Quanb, Rekha S. Iyera, Michelle W. Leec, Krista K. Bowmana, Melissa A. Starovasnika, and Erin C. Dueberb,2 Departments of aStructural Biology, bEarly Discovery Biochemistry, and cProtein Chemistry, Genentech, South San Francisco, CA 94080 Edited by Tony Hunter, Salk Institute for Biological Studies, La Jolla, CA, and approved April 25, 2012 (received for review December 30, 2011) Tank-binding kinase (TBK)1 plays a central role in innate immunity: it the C-terminal scaffolding/dimerization domain (SDD), a do- serves as an integrator of multiple signals induced by receptor- main arrangement that appears to be shared among the IKK mediated pathogen detection and as a modulator of IFN levels. family of kinases (3). Deletion or mutation of the ULD in TBK1 Efforts to better understand the biology of this key immunological or IKKε severely impairs kinase activation and substrate phos- factor have intensified recently as growing evidence implicates phorylation in cells (22, 23). Furthermore, the integrity of the aberrant TBK1 activity in a variety of autoimmune diseases and ULD in IKKβ is not only required for kinase activity (24) but was fi cancers. Nevertheless, key molecular details of TBK1 regulation and shown also to confer substrate speci city in conjunction with the β substrate selection remain unanswered. Here, structures of phos- adjacent SDD (25). Recent crystal structures of the IKK phorylated and unphosphorylated human TBK1 kinase and ubiq- homodimer demonstrate that the ULD and SDD form a joint, uitin-like domains, combined with biochemical studies, indicate three-way interface with the KD within each protomer of the a molecular mechanism of activation via transautophosphorylation. dimer, suggesting that the ULD and SDD serve to buttress the These TBK1 structures are consistent with the tripartite architecture KD as well as to contribute additional binding surfaces that observed recently for the related kinase IKKβ, but domain contribu- properly orient substrates (25). Here we report the crystal structure of the kinase and ubiq- tions toward target recognition appear to differ for the two uitin-like domains (KU) of TBK1 in complex with a potent small- enzymes. In particular, both TBK1 autoactivation and substrate spec- molecule inhibitor, BX795. This structure unexpectedly reveals ificity are likely driven by signal-dependent colocalization events. an activation loop-swapped TBK1 conformation: S172 from one BIOCHEMISTRY protomer is located in close proximity to the active site of the kinase activation | crystallography neighboring protomer, providing a snapshot of a potential transautoactivation reaction intermediate. Biochemical analyses nvading bacteria and viruses possess distinct molecular sig- further demonstrate that the kinase domain alone is sufficient to Inatures that are recognized by conserved host receptors, thereby fully autoactivate and is capable of phosphorylating both mac- triggering the assembly of signaling complexes that activate the romolecular and peptide substrates. A high-resolution structure inhibitor of κB kinase (IKK) family of kinases (1–3). The canonical of monophosphorylated TBK1 KD reveals that S172 phosphor- IKKs (IKKα and IKKβ) in turn induce NF-κB–dependent gene ylation reorganizes the activation segment into a conventional transcription via phosphorylation of the inhibitory κBα (IκBα) configuration that is compatible with polypeptide substrate protein. This modification marks IκBα for K48-linked poly- binding. Taken together, these results offer insights into the ubiquitination and subsequent proteasomal degradation, resulting structural basis of TBK1 transautophosphorylation, highlight the in the release of free NF-κB to up-regulate expression of proin- structural transitions accompanying TBK1 activation, and sup- flammatory cytokines (4). By contrast, activated IKK-related port a model in which TBK1 recruitment to discrete signaling kinases [Tank-binding kinase (TBK)1 and IKKε] directly phos- complexes induces TBK1 activation through proximity. phorylate IFN regulatory factors 3 and 7 (IRF3 and IRF7). Phosphorylation promotes the dimerization and nuclear trans- Results location of these transcription factors that stimulate production of Domain Organization of TBK1 Is Consistent with the IKKβ Tripartite type I interferons (IFNs) (1, 3, 5). Recent studies have identified Architecture. To understand how the KD and ULD are organized an additional role for TBK1 in the xenophagic elimination of within TBK1, we crystallized a fragment of human TBK1 con- bacteria (6–9) and better-defined how cross-talk within the IKK taining both domains and a catalytic residue mutation (KU ; family regulates innate immune response (10). D135N residues Q2–E385) in the presence of an inhibitor, BX795 (26, Under pathological conditions, IKK-mediated pathways can 27). The structure was solved to 2.6-Å resolution by single- also be activated inappropriately by endogenous signals, contrib- fl wavelength anomalous dispersion using a selenomethionine- uting to in ammatory disorders and oncogenesis (11, 12). Whereas A canonical IKKs have long been recognized as bridges between substituted sample (Fig. S1 and Table S1). Both molecules in the chronic inflammation and cancer, IKK-related kinases more re- asymmetric unit demonstrate a tandem arrangement of the kinase cently have also been implicated in cell transformation and tumor and ubiquitin-like domains, which possess the typical bilobe progression (13). TBK1 has been of particular interest, given its identification both as an activator of the oncogenic AKT kinase (14–18) and as an essential factor in KRAS-driven cancers (19). Author contributions: X.M., E.H., Q.T.P., and E.C.D. designed research; X.M., E.H., Q.T.P., R.S.I., TBK1 activity is regulated by phosphorylation on S172 within M.W.L., K.K.B., and E.C.D. performed research; E.H., C.L.Q., R.S.I., and K.K.B. contributed new reagents/analytic tools; X.M., E.H., Q.T.P., M.W.L., M.A.S., and E.C.D. analyzed data; and X.M., the classical kinase activation loop. Serine-to-alanine substitution E.H., M.A.S., and E.C.D. wrote the paper. at this position abolishes TBK1 activity, whereas the phospho- Conflict of interest statement: All authors are employees of Genentech. mimetic mutation S172E partially restores activity to within ∼200- fold of the wild-type kinase (20). Genetic and pharmacological This article is a PNAS Direct Submission. inhibition studies have indicated that TBK1 can be activated by Freely available online through the PNAS open access option. IKKβ, as well as by apparent autophosphorylation (10). Addi- Data deposition: Atomic coordinates and structure factors reported in this paper have tional posttranslational modifications of TBK1 lysine residues by been deposited in the Protein Data Bank, www.pdb.org (PDB ID codes 4EUT and 4EUU). K63-linked polyubiquitin chains have been shown to promote 1X.M. and E.H. contributed equally to this work. production of IFNs in viral infections (21). 2To whom correspondence should be addressed. E-mail: [email protected]. TBK1 contains a predicted ubiquitin-like domain (ULD) (22) This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. that is located between the N-terminal kinase domain (KD) and 1073/pnas.1121552109/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1121552109 PNAS Early Edition | 1of6 Downloaded by guest on September 30, 2021 kinase and ubiquitin folds, respectively (Fig. 1A). In this config- occupied by the αAL-helix of the neighboring protomer in the uration, the ULD abuts the C-terminal lobe (C lobe) of the KD. TBK1 structure (Fig. S4B). Thus, although the unphosphorylated The conventional hydrophobic surface patch of the ULD, which KUD135N structure is endowed with many active kinase traits, the often serves as a protein–protein interaction surface in the case of domain-swapped form is not compatible with substrate binding ubiquitin, faces away from the kinase domain. and, therefore, would not act on a polypeptide substrate. However, A very similar domain organization is observed for IKKβ (25). S172, located in the αAL of the exchanged TBK1 activation loop, is Superposition of the TBK1 KUD135N fragment onto the full- only 6 Å away from the P0 site of the PKA substrate and less than length IKKβ structure (via alignment of the kinase domains) 11 Å from the catalytic D135 residue. Elevated temperature factors appears to poise both TBK1 domains for interaction with the in the αAL-helix underscore the dynamic nature of the TBK1 ac- SDD (Fig. 1B). Residues identified in the KD–SDD and ULD– tivation loop (Fig. S4C) and suggest that a local reorganization of SDD interfaces of the IKKβ structure show moderate conserva- this region, which would allow phosphotransfer to S172, may be tion across IKK-family members and map to comparable surfaces plausible. B of the TBK1 KUD135N fragment structure (Fig. 1 and Fig. S2); The extended interface created by this KUD135N loop swapping however, the orientation of the ULD relative to the KD differs is comparable in size and composition to bona fide protein–pro- slightly in the two kinase structures (Fig. 1A, Inset). In the full- tein complexes, burying 2,570 Å2 of surface area per molecule. β ∼ β length IKK structure, an 30° rotation in the IKK ULD relative However, despite this extensive interaction surface, KUD135N β ’ to that of TBK1 allows the IKK ULD s hydrophobic patch to was found to be monomeric in solution (Fig. 2B). KUD135N, and A B bind to the adjacent SDD (Fig. S3 and ). Similarly, an insertion a shorter construct containing just the kinase domain (KDD135N; into the KD fold specific to IKK-family members (residues 241– Q2–R308), both behaved as monomers by size-exclusion chro- 265 in TBK1) also appears to rearrange in the presence of the matography (SEC). By contrast, full-length TBK1 (FLD135N;Q2– SDD (Fig. S3 C and D). Despite these minor differences, the L729) containing the C-terminal SDD eluted as a dimer.
Load more

Recommended publications
  • Expression and Prognostic Role of IKBKE and TBK1 in Stage I Non-Small Cell Lung Cancer
    Cancer Management and Research Dovepress open access to scientific and medical research Open Access Full Text Article ORIGINAL RESEARCH Expression and prognostic role of IKBKE and TBK1 in stage I non-small cell lung cancer This article was published in the following Dove Press journal: Cancer Management and Research Xin Wang1,2 Background: The inhibitors of nuclear factor kappa-B kinase subunit epsilon (IKBKE) and Feifei Teng2 TANK-binding kinase 1 (TBK1) are important members of the nonclassical IKK family that Jie Lu3 share the kinase domain. They are important oncogenes for activation of several signaling Dianbin Mu4 pathways in several tumors. This study aims to explore the expression of IKBKE and TBK1 Jianbo Zhang4 and their prognostic role in stage I non-small cell lung cancer (NSCLC). Jinming Yu1,2 Patients and methods: A total of 142 surgically resected stage I NSCLC patients were enrolled and immunohistochemistry of IKBKE and TBK1 was performed. 1 Department of Oncology, Renmin Results: IKBKE and TBK1 were expressed in 121 (85.2%) and 114 (80.3%) of stage I Hospital of Wuhan University, Wuhan, fi Hubei 430060, People’s Republic of China; NSCLC patients respectively. IKBKE expression was signi cantly associated with TBK1 2Department of Radiation Oncology, expression (P=0.004). Furthermore, multivariate regression analyses showed there was a fi Shandong Cancer Hospital Af liated to significant relationship between patients with risk factors, the recurrence pattern of metas- Shandong University, Shandong Academy of Medical Sciences, Jinan, Shandong tasis and IKBKE+/TBK1+ co-expression (P=0.032 and P=0.022, respectively). In Kaplan– 250117, People’s Republic of China; Meier survival curve analyses, the IKBKE+/TBK1+ co-expression subgroup was signifi- 3Department of Neurosurgery, Shandong Province Qianfoshan Hospital of Shandong cantly associated with poor overall survival (P=0.014).
    [Show full text]
  • HER2 Stabilizes EGFR and Itself by Altering Autophosphorylation Patterns in a Manner That Overcomes Regulatory Mechanisms and Pr
    Oncogene (2013) 32, 4169–4180 & 2013 Macmillan Publishers Limited All rights reserved 0950-9232/13 www.nature.com/onc ORIGINAL ARTICLE HER2 stabilizes EGFR and itself by altering autophosphorylation patterns in a manner that overcomes regulatory mechanisms and promotes proliferative and transformation signaling Z Hartman1, H Zhao1 and YM Agazie1,2 One of the causes of breast cancer is overexpression of the human epidermal growth factor receptor 2 (HER2). Enhanced receptor autophosphorylation and resistance to activation-induced downregulation have been suggested as mechanisms for HER2-induced sustained signaling and cell transformation. However, the molecular mechanisms underlying these possibilities remain incompletely understood. In the current report, we present evidence that show that HER2 overexpression does not lead to receptor hyper-autophosphorylation, but alters patterns in a manner that favors receptor stability and sustained signaling. Specifically, HER2 overexpression blocks epidermal growth factor receptor (EGFR) tyrosine phosphorylation on Y1045 and Y1068, the known docking sites of c-Cbl and Grb2, respectively, whereas promoting phosphorylation on Y1173, the known docking site of the Gab adaptor proteins and phospholipase C gamma. Under these conditions, HER2 itself is phosphorylated on Y1221/1222, with no known role, and on Y1248 that corresponds to Y1173 of EGFR. Interestingly, suppressed EGFR autophosphorylation on the Grb2 and c-Cbl-binding sites correlated with receptor stability and sustained signaling, suggesting that HER2 accomplishes these tasks by altering autophosphorylation patterns. In conformity with these findings, mutation of the Grb2-binding site on EGFR (Y1068F–EGFR) conferred resistance to ligand-induced degradation, which in turn induced sustained signaling, and increased cell proliferation and transformation.
    [Show full text]
  • Understanding and Exploiting Post-Translational Modifications for Plant Disease Resistance
    biomolecules Review Understanding and Exploiting Post-Translational Modifications for Plant Disease Resistance Catherine Gough and Ari Sadanandom * Department of Biosciences, Durham University, Stockton Road, Durham DH1 3LE, UK; [email protected] * Correspondence: [email protected]; Tel.: +44-1913341263 Abstract: Plants are constantly threatened by pathogens, so have evolved complex defence signalling networks to overcome pathogen attacks. Post-translational modifications (PTMs) are fundamental to plant immunity, allowing rapid and dynamic responses at the appropriate time. PTM regulation is essential; pathogen effectors often disrupt PTMs in an attempt to evade immune responses. Here, we cover the mechanisms of disease resistance to pathogens, and how growth is balanced with defence, with a focus on the essential roles of PTMs. Alteration of defence-related PTMs has the potential to fine-tune molecular interactions to produce disease-resistant crops, without trade-offs in growth and fitness. Keywords: post-translational modifications; plant immunity; phosphorylation; ubiquitination; SUMOylation; defence Citation: Gough, C.; Sadanandom, A. 1. Introduction Understanding and Exploiting Plant growth and survival are constantly threatened by biotic stress, including plant Post-Translational Modifications for pathogens consisting of viruses, bacteria, fungi, and chromista. In the context of agriculture, Plant Disease Resistance. Biomolecules crop yield losses due to pathogens are estimated to be around 20% worldwide in staple 2021, 11, 1122. https://doi.org/ crops [1]. The spread of pests and diseases into new environments is increasing: more 10.3390/biom11081122 extreme weather events associated with climate change create favourable environments for food- and water-borne pathogens [2,3]. Academic Editors: Giovanna Serino The significant estimates of crop losses from pathogens highlight the need to de- and Daisuke Todaka velop crops with disease-resistance traits against current and emerging pathogens.
    [Show full text]
  • Workflows for Rapid Functional Annotation of Diverse
    insects Article Workflows for Rapid Functional Annotation of Diverse Arthropod Genomes Surya Saha 1,2 , Amanda M. Cooksey 2,3, Anna K. Childers 4 , Monica F. Poelchau 5 and Fiona M. McCarthy 2,* 1 Boyce Thompson Institute, 533 Tower Rd., Ithaca, NY 14853, USA; [email protected] 2 School of Animal and Comparative Biomedical Sciences, University of Arizona, 1117 E. Lowell St., Tucson, AZ 85721, USA; [email protected] 3 CyVerse, BioScience Research Laboratories, University of Arizona, 1230 N. Cherry Ave., Tucson, AZ 85721, USA 4 Bee Research Laboratory, Beltsville Agricultural Research Center, Agricultural Research Service, USDA, 10300 Baltimore Ave., Beltsville, MD 20705, USA; [email protected] 5 National Agricultural Library, Agricultural Research Service, USDA, 10301 Baltimore Ave., Beltsville, MD 20705, USA; [email protected] * Correspondence: fi[email protected] Simple Summary: Genomic technologies are accumulating information about genes faster than ever before, and sequencing initiatives, such as the Earth BioGenome Project, i5k, and Ag100Pest Initiative, are expected to increase this rate of acquisition. However, if genomic sequencing is to be used for the improvement of human health, agriculture, and our understanding of biological systems, it is necessary to identify genes and understand how they contribute to biological outcomes. While there are several well-established workflows for assembling genomic sequences and identifying genes, understanding gene function is essential to create actionable knowledge. Moreover, this functional annotation process must be easily accessible and provide information at a genomic scale to keep up Citation: Saha, S.; Cooksey, A.M.; with new sequence data. We report a well-defined workflow for rapid functional annotation of whole Childers, A.K.; Poelchau, M.F.; proteomes to produce Gene Ontology and pathways information.
    [Show full text]
  • Downloaded As a CSV Dump file
    cells Article Transcriptome and Methylome Analysis Reveal Complex Cross-Talks between Thyroid Hormone and Glucocorticoid Signaling at Xenopus Metamorphosis Nicolas Buisine 1,† , Alexis Grimaldi 1,†, Vincent Jonchere 1,† , Muriel Rigolet 1, Corinne Blugeon 2 , Juliette Hamroune 2 and Laurent Marc Sachs 1,* 1 UMR7221 Molecular Physiology and Adaption, CNRS, Museum National d’Histoire Naturelle, 57 Rue Cuvier, CEDEX 05, 75231 Paris, France; [email protected] (N.B.); [email protected] (A.G.); [email protected] (V.J.); [email protected] (M.R.) 2 Genomics Core Facility, Département de Biologie, Institut de Biologie de l’ENS (IBENS), École Normale Supérieure, CNRS, INSERM, Université PSL, 75005 Paris, France; [email protected] (C.B.); [email protected] (J.H.) * Correspondence: [email protected] † Co-first authors, alphabetic order. Abstract: Background: Most work in endocrinology focus on the action of a single hormone, and very little on the cross-talks between two hormones. Here we characterize the nature of interactions between thyroid hormone and glucocorticoid signaling during Xenopus tropicalis metamorphosis. Methods: We used functional genomics to derive genome wide profiles of methylated DNA and measured changes of gene expression after hormonal treatments of a highly responsive tissue, tailfin. Clustering classified the data into four types of biological responses, and biological networks were Citation: Buisine, N.; Grimaldi, A.; modeled by system biology. Results: We found that gene expression is mostly regulated by either Jonchere, V.; Rigolet, M.; Blugeon, C.; T or CORT, or their additive effect when they both regulate the same genes. A small but non- Hamroune, J.; Sachs, L.M.
    [Show full text]
  • Mechanisms of IKBKE Activation in Cancer Sridevi Challa University of South Florida, [email protected]
    University of South Florida Scholar Commons Graduate Theses and Dissertations Graduate School 1-29-2017 Mechanisms of IKBKE Activation in Cancer Sridevi Challa University of South Florida, [email protected] Follow this and additional works at: http://scholarcommons.usf.edu/etd Part of the Biochemistry Commons, Biology Commons, and the Cell Biology Commons Scholar Commons Citation Challa, Sridevi, "Mechanisms of IKBKE Activation in Cancer" (2017). Graduate Theses and Dissertations. http://scholarcommons.usf.edu/etd/6617 This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. Mechanisms of IKBKE Activation in Cancer by Sridevi Challa A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Department of Cell Biology, Microbiology, and Molecular Biology College of Arts and Sciences University of South Florida Major Professor: Mokenge P. Malafa, M.D. Gary Reuther, Ph.D. Eric Lau, Ph.D. Domenico Coppola, M.D. Date of Approval: January 12, 2017 Keywords: EGFR, Olaparib, resistance Copyright © 2017, Sridevi Challa DEDICATION This dissertation is dedicated to my kind and courageous mother. ACKNOWLEDGMENTS I would like to acknowledge Dr. Cheng for trusting me with completion of the projects. I would like to thank him for giving me the freedom to explore any aspect of research and always willing to provide the necessary resources and guidance for my projects. I want to also acknowledge Ted and the Cheng lab personnel for their support.
    [Show full text]
  • Cysteine-179 of Iκb Kinase Β Plays a Critical Role in Enzyme Activation by Promoting Phosphorylation of Activation Loop Serines
    EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 38, No. 5, 546-552, October 2006 Cysteine-179 of IκB kinase β plays a critical role in enzyme activation by promoting phosphorylation of activation loop serines Mi-Sun Byun, Jin Choi and interaction with ATP. Dae-Myung Jue1 Keywords: cysteine; IκB kinase; NF-κB; phosphor- Department of Biochemistry, College of Medicine ylation; protein serine-threonine kinases The Catholic University of Korea Seoul 137-701, Korea 1Corresponding author: Tel, 82-2-590-1177; Introduction Fax, 82-2-596-4435; E-mail, [email protected] Nuclear factor-κB (NF-κB) is a transcription factor that regulates expression of a wide range of cellular Accepted 20 September 2006 and viral genes that play pivotal roles in immune and 12-14 inflammatory responses (Barnes and Karin, 1997). Abbreviations: 15dPGJ2, 15-deoxy-∆ -PGJ2; GST, glutathione In unstimulated cells, NF-κB is associated with S-transferase; HA, hemagglutinin; IKK, IκB kinase; MAPKKK, mito- inhibitory IκB proteins that inhibit nuclear localization gen-activated protein kinase kinase kinase; MEKK, MAPK/ and DNA binding of NF-κB. In response to stimuli extracellular signal-regulated kinase kinase; NIK, NF-κB-inducing including TNF, IL-1, LPS, or viruses, the IκBs are kinase phosphorylated and subsequently degraded, releasing NF-κB to bind DNA and induce expression of specific Abstract target genes. Phosphorylation of IκB is one of the primary IκB kinase β (IKKβ) subunit of IKK complex is points of regulation in NF-κB activation pathway, and essential for the activation of NF-κB in response to occurs by IκB kinase (IKK). IKK is present as a various proinflammatory signals.
    [Show full text]
  • Supp Material.Pdf
    Supplemental Material STRESS-INDUCED H3S28 PHOSPHORYLATION MODULATES LOCAL HISTONE ACETYLATION LEVELS Anna Sawicka, Dominik Hartl, Malgorzata Goiser, Oliver Pusch, Roman R Stocsits, Ido M Tamir, Karl Mechtler, Christian Seiser Supplemental Methods Supplemental Figure Legends Supplemental Tables (SUPPL. TABLES 1-2, 4-5) Supplemental Tables (SUPPL. TABLES 3, 6-9, provided as txt files) References Supplemental Figures (SUPPL. FIGURES 1-21) Supplemental Methods Histone peptides used for the pull-down assay and mass spectrometry analysis: H3unmodified (3-20): H2N-TKQTARKSTGGKAPRKQLC-CONH2 H3S10phK14ac (3-20): H2N-TKQTARKS(ph)TGGK(Ac)APRKQLC -CONH2 H3unmodified (19-36): H2N-QLATKAARKSAPATGGVKKC-CONH2 H3S28ph (19-36): H2N-QLATKAARKS(ph)APATGGVKKC-CONH2 Histone peptide pull-down assay For histone peptide pull down assays, 0.1 mg of synthetic peptides (peptide sequences are given above), corresponding to amino acids 3-20 and 19-36 of histone H3 (numbered from N-terminus of histone H3) with a C-terminal cysteine added were coupled to 40 µl (bed volume) of SulfoLink Coupling Resin (Thermo Scientific) according to the manufacturerʼs instructions. Peptide-coupled resin was incubated overnight at 4oC on a roller with 500 µg of nuclear extract (isolated from proliferating HeLa cells treated with 188.5 nM Anisomycin for 1 hour) diluted to 0.5 µg/µl in the binding buffer (20 mM Tris-HCl pH 8.0, 135 mM NaCl, 0.5% NP40, 10% glycerol). The beads were washed 3 times 20 mM Tris-HCl pH 8.0, 135 mM NaCl, 0.5% NP40, 10% glycerol, followed by two washes with 200 mM NaCl, 50 mM Tris-HCl pH 8.0, 0.1 % SDS, 0.1% NP40, 0.5% sodium deoxycholate.
    [Show full text]
  • The Human Gene Connectome As a Map of Short Cuts for Morbid Allele Discovery
    The human gene connectome as a map of short cuts for morbid allele discovery Yuval Itana,1, Shen-Ying Zhanga,b, Guillaume Vogta,b, Avinash Abhyankara, Melina Hermana, Patrick Nitschkec, Dror Friedd, Lluis Quintana-Murcie, Laurent Abela,b, and Jean-Laurent Casanovaa,b,f aSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065; bLaboratory of Human Genetics of Infectious Diseases, Necker Branch, Paris Descartes University, Institut National de la Santé et de la Recherche Médicale U980, Necker Medical School, 75015 Paris, France; cPlateforme Bioinformatique, Université Paris Descartes, 75116 Paris, France; dDepartment of Computer Science, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel; eUnit of Human Evolutionary Genetics, Centre National de la Recherche Scientifique, Unité de Recherche Associée 3012, Institut Pasteur, F-75015 Paris, France; and fPediatric Immunology-Hematology Unit, Necker Hospital for Sick Children, 75015 Paris, France Edited* by Bruce Beutler, University of Texas Southwestern Medical Center, Dallas, TX, and approved February 15, 2013 (received for review October 19, 2012) High-throughput genomic data reveal thousands of gene variants to detect a single mutated gene, with the other polymorphic genes per patient, and it is often difficult to determine which of these being of less interest. This goes some way to explaining why, variants underlies disease in a given individual. However, at the despite the abundance of NGS data, the discovery of disease- population level, there may be some degree of phenotypic homo- causing alleles from such data remains somewhat limited. geneity, with alterations of specific physiological pathways under- We developed the human gene connectome (HGC) to over- come this problem.
    [Show full text]
  • HER2/Neu: an Increasingly Important Therapeutic Target
    Clinical Trial Outcomes NELSON HER2/neu: an increasingly important therapeutic target. Part 1 4 Clinical Trial Outcomes HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium Clin. Invest. This is the first of a comprehensive three-part review of the foundation for and Edward L Nelson therapeutic targeting of HER2/neu. No biological molecule in oncology has been more University of California, Irvine, extensively or more successfully targeted than HER2/neu. This review will summarize School of Medicine; Division of Hematology/Oncology; Department the pertinent biology of HER2/neu and the EGF receptor family to which it belongs, of Medicine; Department of Molecular with attention to the biological foundation for the design and clinical development Biology & Biochemistry; Sprague Hall, of the entire range of HER2/neu-targeted therapies, including efforts to mitigate Irvine, CA 92697, USA resistance mechanisms. In conjunction with the subsequent two parts (HER2/neu tissue [email protected] expression and current HER2/neu-targeted therapeutics), this comprehensive survey will identify opportunities and promising areas for future evaluation of HER2/neu- targeted therapies, highlighting the importance of HER2/neu as an increasingly important therapeutic target. Keywords: c-erbB2 • EGF receptor • EGFR • EGFR ligand • expression modulation • HER2/neu • monoclonal antibody • signaling network • targeted therapeutic • tyrosine kinase inhibitor • vaccine The history of the molecule known as c-erbB2 = neu, c-erbB3 = EGFR-3, and HER2/neu dates back to the earliest stud- eventually, c-erbB4 = EGFR-4) were estab- 10.4155/CLI.14.57 ies of virus-associated oncogenes. In 1979, lished [13] . The fact that the neu molecule studies of avian erythroblastosis virus iden- and coding sequence was originally identi- tified two putative viral oncogenes, v-erbA fied in the rat species and only recently has and v-erbB [1–3] .
    [Show full text]
  • UC San Diego Electronic Theses and Dissertations
    UC San Diego UC San Diego Electronic Theses and Dissertations Title Cardiac Stretch-Induced Transcriptomic Changes are Axis-Dependent Permalink https://escholarship.org/uc/item/7m04f0b0 Author Buchholz, Kyle Stephen Publication Date 2016 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA, SAN DIEGO Cardiac Stretch-Induced Transcriptomic Changes are Axis-Dependent A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Bioengineering by Kyle Stephen Buchholz Committee in Charge: Professor Jeffrey Omens, Chair Professor Andrew McCulloch, Co-Chair Professor Ju Chen Professor Karen Christman Professor Robert Ross Professor Alexander Zambon 2016 Copyright Kyle Stephen Buchholz, 2016 All rights reserved Signature Page The Dissertation of Kyle Stephen Buchholz is approved and it is acceptable in quality and form for publication on microfilm and electronically: Co-Chair Chair University of California, San Diego 2016 iii Dedication To my beautiful wife, Rhia. iv Table of Contents Signature Page ................................................................................................................... iii Dedication .......................................................................................................................... iv Table of Contents ................................................................................................................ v List of Figures ...................................................................................................................
    [Show full text]
  • MITF—The First 25 Years
    Downloaded from genesdev.cshlp.org on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press SPECIAL SECTION: REVIEW MITF—the first 25 years Colin R. Goding1 and Heinz Arnheiter2 1Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford OX3 7DQ, United Kingdom; 2National Institute of Neurological Disorders and Stroke, National Institutes of Heath, Bethesda, Maryland 20824, USA All transcription factors are equal, but some are more ness, microphthalmia (Fig. 1A), and deafness and, depend- equal than others. In the 25 yr since the gene encod- ing on the allele, may show auxiliary symptoms such as ing the microphthalmia-associated transcription factor osteopetrosis, mast cell deficiencies, heart hypotrophy, (MITF) was first isolated, MITF has emerged as a key co- or altered nephron numbers. In some cases only a minor ordinator of many aspects of melanocyte and melanoma reduction in the levels of the pigment enzyme tyrosinase biology. Like all transcription factors, MITF binds to spe- is observed, as seen with homozygosity for mi-spotted, cific DNA sequences and up-regulates or down-regulates an allele that was found only because it renders mice spot- its target genes. What marks MITF as being remarkable ted when combined with other mi alleles. Because the among its peers is the sheer range of biological proces- phenotypes associated with specific alleles or allele ses that it appears to coordinate. These include cell sur- combinations reveal a high degree of complexity, it was vival, differentiation, proliferation, invasion, senescence, originally thought that the full phenotypic spectrum asso- metabolism, and DNA damage repair.
    [Show full text]